Fares B.
Director In Vivo Pharmacology Gene Therapy @ Eli Lilly and Company
About Fares B.
Fares B. is the Director of In Vivo Pharmacology Gene Therapy at Eli Lilly and Company, a position he has held since 2022. He has an extensive academic background in neuroscience and pharmacology, with a Ph.D. from Université de Bordeaux and experience at AbbVie and the University of Pennsylvania.